Position in LRMR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,893,657
+$1,375,563 QoQ
Shares Held
420,813
+209.5% QoQ
Ownership
0.405%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. LRMR ranks #219 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in LRMR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,893,657 | 420,813 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $518,094 | 135,983 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $300,396 | 93,003 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $488,518 | 169,038 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $884,463 | 411,380 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $658,590 | 170,179 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $977,441 | 149,228 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $388,691 | 53,613 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $358,921 | 47,289 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $255,770 | 56,214 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $96,115 | 24,334 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $101,366 | 32,386 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $291,675 | 64,388 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,233,655 | 540,837 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,696,937 | 530,293 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,038,422 | 529,808 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,146,434 | 529,984 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $127,265 | 11,795 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $404,240 | 35,060 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $339,652 | 34,588 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $381,569 | 26,117 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $707,707 | 33,055 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $816,145 | 53,800 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $458,589 | 35,688 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||